Margaret Ottaviano, Domenico Mallardo, Ester Simeone, Michele Del Vecchio, Jacopo Pigozzo, Laura Ridolfi, Virginia Ferraresi, Mario Mandala, Teresa Troiani, Giuseppe Curigliano, Miriam Paone, Corrado Caraco, Diana Giannarelli, Nina Merchant, Arash Yavari, Christian U. Blank, Paolo Antonio Ascierto. "A multicenter, randomized phase Ib trial to evaluate neoadjuvant immunotherapy combination of nivolumab alone or plus ipilimumab with the IL-2 superkine MDNA11 alone or with tocilizumab in patients with high-risk, surgically resectable melanoma: The NEO-CYT trial.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps9612